BioCatalyst

Bimekizumab — catalyst calendar

2 verified catalyst event(s) referencing Bimekizumab, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08-07
in 1d
ESTIMATED
 READOUT
A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizum
Phase 3 · Axial Spondyloarthritis, Ankylosing Spondylitis
 UCB Biopharma SRL Bimekizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
2026-12-21
in 5mo
ESTIMATED
 READOUT
A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and
Phase 3 · Hidradenitis Suppurativa
 UCB Biopharma SRL Bimekizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.